NOK 5.01
(-3.65%)
Year | Eps | Eps Growth |
---|---|---|
2023 | -1.19 NOK | 2.46% |
2022 | -1.22 NOK | -16.19% |
2021 | -1.05 NOK | 2.78% |
2020 | -1.08 NOK | 38.64% |
2019 | -1.76 NOK | 25.11% |
2018 | -2.53 NOK | -35.84% |
2017 | -1.73 NOK | -37.3% |
2016 | -1.26 NOK | 25.44% |
2015 | -1.69 NOK | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q2 | -0.34 NOK | -41.67% |
2024 Q1 | -0.24 NOK | 42.86% |
2024 Q3 | -0.20 NOK | 41.18% |
2023 Q3 | -0.33 NOK | 2.94% |
2023 Q2 | -0.34 NOK | -21.43% |
2023 FY | - NOK | 2.46% |
2023 Q1 | -0.28 NOK | 6.67% |
2023 Q4 | -0.42 NOK | -27.27% |
2022 FY | - NOK | -16.19% |
2022 Q2 | -0.31 NOK | 18.42% |
2022 Q3 | -0.24 NOK | 22.58% |
2022 Q4 | -0.30 NOK | -25.0% |
2022 Q1 | -0.38 NOK | -137.5% |
2021 Q4 | -0.16 NOK | -33.33% |
2021 Q1 | -0.48 NOK | 66.2% |
2021 Q2 | -0.34 NOK | 29.17% |
2021 Q3 | -0.12 NOK | 64.71% |
2021 FY | - NOK | 2.78% |
2020 Q4 | -1.42 NOK | -1083.33% |
2020 Q3 | -0.12 NOK | 57.14% |
2020 Q2 | -0.28 NOK | 36.36% |
2020 Q1 | -0.44 NOK | 88.48% |
2020 FY | - NOK | 38.64% |
2019 Q3 | -0.33 NOK | 0.0% |
2019 FY | - NOK | 25.11% |
2019 Q2 | -0.33 NOK | 2.94% |
2019 Q1 | -0.34 NOK | 80.23% |
2019 Q4 | -3.82 NOK | -1057.58% |
2018 Q4 | -1.72 NOK | -132.43% |
2018 FY | - NOK | -35.84% |
2018 Q1 | -0.49 NOK | 77.93% |
2018 Q2 | -1.91 NOK | -289.8% |
2018 Q3 | -0.74 NOK | 61.26% |
2017 Q4 | -2.22 NOK | -500.0% |
2017 Q1 | -0.40 NOK | 31.03% |
2017 Q2 | -0.33 NOK | 17.5% |
2017 Q3 | -0.37 NOK | -12.12% |
2017 FY | - NOK | -37.3% |
2016 Q2 | -0.60 NOK | 50.0% |
2016 Q1 | -1.20 NOK | 0.0% |
2016 FY | - NOK | 25.44% |
2016 Q4 | -0.58 NOK | -45.0% |
2016 Q3 | -0.40 NOK | 33.33% |
2015 FY | - NOK | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Kitron ASA | 2.95 NOK | 140.339% |
NEXT Biometrics Group ASA | -0.69 NOK | -72.464% |
Norbit ASA | 3.11 NOK | 138.264% |